Brief ReportBrief Report

Brucellosis and Sacroiliitis: A Common Presentation of an Uncommon Pathogen

James R. Priest, Dennis Low, Cliff Wang and Thomas Bush
The Journal of the American Board of Family Medicine March 2008, 21 (2) 158-161; DOI: https://doi.org/10.3122/jabfm.2008.02.070170

References

  1. ↵
    Hing E, Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2004 summary. Adv Data 2006; (374): 1–33.
    OpenUrlPubMed
  2. ↵
    Middleton KR, Hing E. National Hospital Ambulatory Medical Care Survey: 2004 outpatient department summary. Adv Data 2006; (373): 1–27.
    OpenUrlPubMed
  3. ↵
    Gonzalez-Gay MA, Garcia-Porrua C, Ibanez D, Garcia-Pais MJ. Osteoarticular complications of brucellosis in an Atlantic area of Spain. J Rheumatol 1999; 26: 141–5.
    OpenUrlPubMedWeb of Science
  4. ↵
    Park MY, Lee CS, Choi YS, Park SJ, Lee JS, Lee HB. A sporadic outbreak of human brucellosis in Korea. J Korean Med Sci 2005; 20: 941–6.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    Ashford DA, di Pietra J, Lingappa J, et al. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine 2004; 22: 3435–9.
    OpenUrlCrossRefPubMed
  6. ↵
    Jimenez de Bagues MP, Dudal S, Dornand J, Gross A. Cellular bioterrorism: how Brucella corrupts macrophage physiology to promote invasion and proliferation. Clin Immunol 2005; 114: 227–38.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    Al Sekait M. Seroepidemiological survey of brucellosis antibodies in Saudi Arabia. Ann Saudi Med 1999; 19: 219–22.
    OpenUrlPubMedWeb of Science
  8. ↵
    Pappas G, Panagopoulou P, Christou L, Akritidis N. Brucella as a biological weapon. Cell Mol Life Sci 2006; 63: 2229–36.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    Troy SB, Rickman LS, Davis CE. Brucellosis in San Diego: epidemiology and species-related differences in acute clinical presentations. Medicine (Baltimore) 2005; 84: 174–87.
    OpenUrlCrossRefPubMed
  10. ↵
    Cetinkaya Z, Aktepe OC, Ciftci IH, Demirel R. Seroprevalence of human brucellosis in a rural area of Western Anatolia, Turkey. J Health Popul Nutr 2005; 23: 137–41.
    OpenUrlPubMed
  11. ↵
    Lopez-Merino A, Migranas-Ortiz R, Perez-Miravete A, et al. [Seroepidemiology of brucellosis in Mexico]. Salud Publica Mex 1992; 34: 230–40.
    OpenUrlPubMed
  12. ↵
    Reid AJ. Brucellosis a persistent occupational hazard in Ireland. Int J Occup Environ Health 2005; 11: 302–4.
    OpenUrlPubMed
  13. ↵
    Torre I, Ribera G, Pavia M, Angelillo IF. A seroepidemiologic survey on brucellosis antibodies in southern Italy. Infection 1997; 25: 150–3.
    OpenUrlPubMed
  14. ↵
    McNabb SJ, Jajosky RA, Hall-Baker PA, et al. Summary of notifiable diseases United States, 2005. MMWR Morb Mortal Wkly Rep 2007; 54: 1–92.
    OpenUrlPubMed
  15. ↵
    Al Dahouk S, Nockler K, Hensel A, et al. Human brucellosis in a nonendemic country: a report from Germany, 2002 and 2003. Eur J Clin Microbiol Infect Dis 2005; 24: 450–6.
    OpenUrlCrossRefPubMedWeb of Science
  16. Bouza E, Sanchez-Carrillo C, Hernangomez S, Gonzalez MJ. Laboratory-acquired brucellosis: a Spanish national survey. J Hosp Infect 2005; 61: 80–3.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    Noviello S, Gallo R, Kelly M, et al. Laboratory-acquired brucellosis. Emerg Infect Dis 2004; 10: 1848–50.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    Colmenero JD, Reguera JM, Martos F, et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore) 1996; 75: 195–211.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    Dokuzoguz B, Ergonul O, Baykam N, et al. Characteristics of B. melitensis versus B. abortus bacteraemias. J Infect 2005; 50: 41–5.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    Pourbagher MA, Pourbagher A, Savas L, et al. Clinical pattern and abdominal sonographic findings in 251 cases of brucellosis in southern Turkey. AJR AJR 2006; 187: W191–4.
    OpenUrl
  21. ↵
    Press J, Peled N, Buskila D, Yagupsky P. Leukocyte count in the synovial fluid of children with culture-proven brucellar arthritis. Clin Rheumatol 2002; 21: 191–3.
    OpenUrlPubMed
  22. ↵
    Ersoy Y, Sonmez E, Tevfik MR, But AD. Comparison of three different combination therapies in the treatment of human brucellosis. Trop Doct 2005; 35: 210–2.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    El Miedany YM, El Gaafary M, Baddour M, Ahmed I. Human brucellosis: do we need to revise our therapeutic policy?. J Rheumatol 2003; 30: 2666–72.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Bayindir Y, Sonmez E, Aladag A, Buyukberber N. Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: a prospective, randomized study. J Chemother 2003; 15: 466–71.
    OpenUrlPubMedWeb of Science
  25. ↵
    Solera J, Lozano E, Martinez-Alfaro E, Espinosa A, Castillejos ML, Abad L. Brucellar spondylitis: review of 35 cases and literature survey. Clin Infect Dis 1999; 29: 1440–9.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Solera J, Martinez-Alfaro E, Espinosa A, Castillejos ML, Geijo P, Rodriguez-Zapata M. Multivariate model for predicting relapse in human brucellosis. J Infect 1998; 36: 85–92.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    Hasanjani Roushan MR, Mohraz M, Hajiahmadi M, Ramzani A, Valayati AA. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans. Clin Infect Dis 2006; 42: 1075–80.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section